المؤلفون: Akamatsu H; Department of Hospital Pharmacy, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan. Electronic address: haya-pon@nagasaki-u.ac.jp., Kohno Y; Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan., Hashizume J; Department of Hospital Pharmacy, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan; Department of Medical Safety, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan., Nakagawa H; Department of Hospital Pharmacy, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan., Kodama Y; Department of Hospital Pharmacy, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan., Kawano H; Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan., Maemura K; Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan., Ohyama K; Department of Hospital Pharmacy, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.

المصدر: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2024 Sep; Vol. 30 (9), pp. 928-933. Date of Electronic Publication: 2024 Feb 13.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9608375 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7780 (Electronic) Linking ISSN: 1341321X NLM ISO Abbreviation: J Infect Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Ritonavir*/adverse effects , Ritonavir*/administration & dosage , Ritonavir*/therapeutic use , Rifampin*/adverse effects , Rifampin*/administration & dosage , Rifampin*/therapeutic use , Drug Interactions* , Dermatomyositis*/drug therapy , Dermatomyositis*/blood , Dermatomyositis*/complications , Tacrolimus*/adverse effects , Tacrolimus*/administration & dosage , Tacrolimus*/blood , Tacrolimus*/therapeutic use, Humans ; Male ; Middle Aged ; COVID-19/complications ; Coronary Vasospasm/chemically induced ; Coronary Vasospasm/drug therapy ; Coronary Vasospasm/blood ; COVID-19 Drug Treatment ; Angina Pectoris/drug therapy ; Angina Pectoris/blood ; SARS-CoV-2 ; Cytochrome P-450 CYP3A Inducers/administration & dosage ; Cytochrome P-450 CYP3A Inducers/adverse effects ; Cytochrome P-450 CYP3A Inducers/therapeutic use ; Acute Kidney Injury/chemically induced ; Acute Kidney Injury/blood

المؤلفون: Lima CR; Laboratory of Biological System Modeling, Centro de Desenvolvimento Tecnológico em Saúde (CDTS), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro 21040-900, Brazil., Antunes D; Laboratório de Genômica Aplicada e Bioinovações, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro 21040-900, Brazil., Caffarena E; Grupo de Biofísica Computacional e Modelagem Molecular, Programa de Computação Científica (PROCC), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro 21040-900, Brazil., Carels N; Laboratory of Biological System Modeling, Centro de Desenvolvimento Tecnológico em Saúde (CDTS), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro 21040-900, Brazil.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 12; Vol. 25 (16). Date of Electronic Publication: 2024 Aug 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Lactams, Macrocyclic*/pharmacology , Lactams, Macrocyclic*/chemistry , Ritonavir*/chemistry , Ritonavir*/pharmacology , Benzoquinones*/chemistry , Benzoquinones*/pharmacology , Benzoquinones*/metabolism , HSP90 Heat-Shock Proteins*/chemistry , HSP90 Heat-Shock Proteins*/metabolism , HSP90 Heat-Shock Proteins*/antagonists & inhibitors, Humans ; Protein Binding ; Molecular Dynamics Simulation ; Molecular Docking Simulation ; Models, Molecular ; Binding Sites ; Adenosine Triphosphate/metabolism ; Adenosine Triphosphate/chemistry

المؤلفون: Chen X; Department of Infectious Diseases, Shanghai Sixth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China., Zhu Y; Department of Pulmonary and Critical Care Medicine, 8th Medical Center of Chinese PLA General Hospital General Hospital, Beijing, China.; Department of Pulmonary and Critical Care Medicine, 7th Medical Center of Chinese PLA General Hospital, Beijing, China., Shen L; Department of Infectious Diseases, Shanghai Sixth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China., Zhou D; Shanghai Key Laboratory of Medical Epigenetics, Laboratory of Cancer Epigenetics, Center for Medical Research and Innovation, Shanghai Pudong Hospital, Institutes of Biomedical Sciences, Medical College of Fudan University, Chinese Academy of Medical Sciences (RU069), Shanghai, China., Feng N; School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Tong Q; Department of Rheumatology & Immunology, Shanghai Sixth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

المصدر: Journal of intensive care medicine [J Intensive Care Med] 2024 Aug; Vol. 39 (8), pp. 742-750. Date of Electronic Publication: 2024 Feb 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 8610344 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1489 (Electronic) Linking ISSN: 08850666 NLM ISO Abbreviation: J Intensive Care Med Subsets: MEDLINE

مواضيع طبية MeSH: Ritonavir*/therapeutic use , Ritonavir*/adverse effects , COVID-19 Drug Treatment* , Disease Progression* , Critical Illness* , Antiviral Agents*/therapeutic use , Antiviral Agents*/adverse effects , SARS-CoV-2* , COVID-19*/mortality , COVID-19*/complications, Humans ; Male ; Female ; Retrospective Studies ; Middle Aged ; Aged ; Hospitalization/statistics & numerical data ; Treatment Outcome ; Viral Load ; Drug Combinations

المؤلفون: Hsu WH; Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan., Shiau BW; Divison of General Medicine, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan., Tsai YW; Center for Integrative Medicine, Chi Mei Medical Center, Tainan City, Taiwan; Department of Medical Laboratory Sciences and Biotechnology, Fooyin University, Kaohsiung, Taiwan., Wu JY; Department of Nutrition, Chi Mei Medical Center, Tainan, Taiwan; Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Huang PY; Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan., Chuang MH; Division of Nephrology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan., Liu TH; Department of Psychiatry, Chi Mei Medical Center, Tainan, Taiwan., Lai CC; Department of Intensive Care Medicine, Chi Mei Medical Center, Tainan, Taiwan; School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan. Electronic address: dtmed141@gmail.com., Weng TC; Division of Hospital Medicine, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan. Electronic address: wengtzuchieh@gmail.com.

المصدر: Journal of infection and public health [J Infect Public Health] 2024 Aug; Vol. 17 (8), pp. 102465. Date of Electronic Publication: 2024 May 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101487384 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-035X (Electronic) Linking ISSN: 18760341 NLM ISO Abbreviation: J Infect Public Health Subsets: MEDLINE

مواضيع طبية MeSH: Antiviral Agents*/therapeutic use , Antiviral Agents*/administration & dosage , Lung Neoplasms*/drug therapy , Lung Neoplasms*/mortality , Ritonavir*/therapeutic use , Ritonavir*/administration & dosage , COVID-19 Drug Treatment* , SARS-CoV-2*, Humans ; Male ; Female ; Retrospective Studies ; Middle Aged ; Aged ; Administration, Oral ; Hospitalization/statistics & numerical data ; COVID-19/mortality ; Hydroxylamines/therapeutic use ; Hydroxylamines/administration & dosage ; Treatment Outcome ; Drug Combinations ; Cytidine/analogs & derivatives

المؤلفون: Xu X; Department of Pharmacy, the First Affiliated Hospital, Sun Yat-sen University, No. 58, Zhong Shan Er Lu, Guangzhou, China.; Institute of Clinical Pharmacology, Sun Yat-sen University, Guangzhou, China., Zhang H; Organ Transplant Center, the First Affiliated Hospital, Sun Yat-sen University, No. 58, Zhong Shan Er Lu, Guangzhou, China., Liu L; Organ Transplant Center, the First Affiliated Hospital, Sun Yat-sen University, No. 58, Zhong Shan Er Lu, Guangzhou, China., Fu Q; Organ Transplant Center, the First Affiliated Hospital, Sun Yat-sen University, No. 58, Zhong Shan Er Lu, Guangzhou, China., Wu C; Organ Transplant Center, the First Affiliated Hospital, Sun Yat-sen University, No. 58, Zhong Shan Er Lu, Guangzhou, China., Lin X; Department of Pharmacy, the First Affiliated Hospital, Sun Yat-sen University, No. 58, Zhong Shan Er Lu, Guangzhou, China., Tang K; Department of Pharmacy, the First Affiliated Hospital, Sun Yat-sen University, No. 58, Zhong Shan Er Lu, Guangzhou, China., Wang C; Organ Transplant Center, the First Affiliated Hospital, Sun Yat-sen University, No. 58, Zhong Shan Er Lu, Guangzhou, China. wangchx@mail.sysu.edu.cn., Chen P; Department of Pharmacy, the First Affiliated Hospital, Sun Yat-sen University, No. 58, Zhong Shan Er Lu, Guangzhou, China. chenp73@mail.sysu.edu.cn.

المصدر: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2024 Aug; Vol. 80 (8), pp. 1219-1227. Date of Electronic Publication: 2024 May 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041 (Electronic) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Kidney Transplantation* , Ritonavir*/pharmacokinetics , Ritonavir*/pharmacology , Drug Interactions* , Calcineurin Inhibitors*/pharmacokinetics , Calcineurin Inhibitors*/pharmacology , Calcineurin Inhibitors*/administration & dosage, Humans ; Male ; Female ; Middle Aged ; Adult ; Cytochrome P-450 CYP3A/metabolism ; Cytochrome P-450 CYP3A/genetics ; Immunosuppressive Agents/pharmacokinetics ; Immunosuppressive Agents/administration & dosage ; Prospective Studies ; Tacrolimus/pharmacokinetics ; Tacrolimus/administration & dosage ; Tacrolimus/pharmacology ; Genotype ; Area Under Curve ; Transplant Recipients

المؤلفون: Jiang J; Department of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, China; Center of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, China; Clinical Research Center for Respiratory Diseases in Hunan Province, Changsha, China; Hunan Engineering Research Center for Intelligent Diagnosis and Treatment of Respiratory Disease, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China., Li Y; Department of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, China; Center of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, China; Clinical Research Center for Respiratory Diseases in Hunan Province, Changsha, China; Hunan Engineering Research Center for Intelligent Diagnosis and Treatment of Respiratory Disease, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China., Jiang Q; Department of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, China; Center of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, China; Clinical Research Center for Respiratory Diseases in Hunan Province, Changsha, China; Hunan Engineering Research Center for Intelligent Diagnosis and Treatment of Respiratory Disease, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China., Jiang Y; Department of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, China; Center of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, China; Clinical Research Center for Respiratory Diseases in Hunan Province, Changsha, China; Hunan Engineering Research Center for Intelligent Diagnosis and Treatment of Respiratory Disease, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China., Qin H; Department of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, China; Center of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, China; Clinical Research Center for Respiratory Diseases in Hunan Province, Changsha, China; Hunan Engineering Research Center for Intelligent Diagnosis and Treatment of Respiratory Disease, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China., Li Y; Department of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, China; Center of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, China; Clinical Research Center for Respiratory Diseases in Hunan Province, Changsha, China; Hunan Engineering Research Center for Intelligent Diagnosis and Treatment of Respiratory Disease, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China. Electronic address: leeround@csu.edu.cn.

المصدر: The Journal of infection [J Infect] 2024 Aug; Vol. 89 (2), pp. 106190. Date of Electronic Publication: 2024 Jun 02.

نوع المنشور: Journal Article; Systematic Review; Meta-Analysis

بيانات الدورية: Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2742 (Electronic) Linking ISSN: 01634453 NLM ISO Abbreviation: J Infect Subsets: MEDLINE

مواضيع طبية MeSH: Antiviral Agents*/therapeutic use , Antiviral Agents*/administration & dosage , Ritonavir*/therapeutic use , Ritonavir*/administration & dosage , Network Meta-Analysis* , COVID-19 Drug Treatment* , SARS-CoV-2* , COVID-19*/epidemiology, Humans ; Administration, Oral ; Drug Combinations ; Hydroxylamines/therapeutic use ; Hydroxylamines/administration & dosage ; Post-Acute COVID-19 Syndrome ; Lactams ; Cytidine/analogs & derivatives ; Nitriles ; Proline ; Leucine

المؤلفون: Mizuno T; Department of Pharmacy, Toyota Kosei Hospital: 500-1, Ibobara, Jousui-cho, Toyota, 470-0396, Japan., Kondo Y; Department of Pharmacy, Toyota Kosei Hospital: 500-1, Ibobara, Jousui-cho, Toyota, 470-0396, Japan. Electronic address: yu.kondoh.0327@gmail.com., Sakai M; Department of Pharmacy, Toyota Kosei Hospital: 500-1, Ibobara, Jousui-cho, Toyota, 470-0396, Japan., Saneyasu K; Department of Pharmacy, Toyota Kosei Hospital: 500-1, Ibobara, Jousui-cho, Toyota, 470-0396, Japan., Kojima R; Department of Pharmacy, Toyota Kosei Hospital: 500-1, Ibobara, Jousui-cho, Toyota, 470-0396, Japan., Miyake Y; Department of Pharmacy, Toyota Kosei Hospital: 500-1, Ibobara, Jousui-cho, Toyota, 470-0396, Japan.

المصدر: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2024 Aug; Vol. 30 (8), pp. 716-724. Date of Electronic Publication: 2024 Feb 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9608375 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7780 (Electronic) Linking ISSN: 1341321X NLM ISO Abbreviation: J Infect Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Cost-Benefit Analysis* , Ritonavir*/therapeutic use , Ritonavir*/economics , COVID-19 Drug Treatment* , Quality-Adjusted Life Years*, Humans ; Japan/epidemiology ; Middle Aged ; Aged ; Adult ; Aged, 80 and over ; Male ; SARS-CoV-2 ; Female ; Antiviral Agents/therapeutic use ; Antiviral Agents/economics ; Outpatients/statistics & numerical data ; COVID-19/economics ; COVID-19/mortality

المؤلفون: Sun CK; Institute of Traditional Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan., Kung YY; Institute of Traditional Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan; Center for Traditional Medicine, Taipei Veterans General Hospital, Taipei 112, Taiwan., Lee WH; Institute of Traditional Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan., Lin LC; National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei 112, Taiwan., Yang MH; Institute of Clinical Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan., Tsai TH; Institute of Traditional Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan; Graduate Institute of Acupuncture Science, China Medical University, Taichung 404, Taiwan; School of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan; Graduate Institute of Law and Interdisciplinary Studies, College of Law, National Chengchi University, Taipei 116, Taiwan. Electronic address: thtsai@nycu.edu.tw.

المصدر: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2024 Aug 01; Vol. 245, pp. 116162. Date of Electronic Publication: 2024 Apr 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: England NLM ID: 8309336 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-264X (Electronic) Linking ISSN: 07317085 NLM ISO Abbreviation: J Pharm Biomed Anal Subsets: MEDLINE

مواضيع طبية MeSH: Ritonavir*/pharmacokinetics , Ritonavir*/pharmacology , Scutellaria baicalensis*/chemistry , Blood-Brain Barrier*/metabolism , Blood-Brain Barrier*/drug effects , Microdialysis*/methods , Rats, Sprague-Dawley* , Herb-Drug Interactions* , Antiviral Agents*/pharmacokinetics , Plant Extracts*/pharmacokinetics , Plant Extracts*/pharmacology, Animals ; Rats ; Male ; Tandem Mass Spectrometry/methods ; Brain/metabolism ; Drugs, Chinese Herbal/pharmacokinetics ; Drugs, Chinese Herbal/pharmacology ; Drugs, Chinese Herbal/administration & dosage

المؤلفون: Sevrioukova IF; Department of Molecular Biology and Biochemistry, University of California, Irvine, CA, 92697-3900, USA. Electronic address: sevrioui@uci.edu.

المصدر: Archives of biochemistry and biophysics [Arch Biochem Biophys] 2024 Aug; Vol. 758, pp. 110071. Date of Electronic Publication: 2024 Jun 22.

نوع المنشور: Journal Article; Comparative Study; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0372430 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0384 (Electronic) Linking ISSN: 00039861 NLM ISO Abbreviation: Arch Biochem Biophys Subsets: MEDLINE

مواضيع طبية MeSH: Cytochrome P-450 CYP3A*/chemistry , Cytochrome P-450 CYP3A*/metabolism , Ritonavir*/chemistry , Ritonavir*/metabolism , Ritonavir*/pharmacology , Cobicistat*/chemistry , Cobicistat*/metabolism , Cytochrome P-450 CYP3A Inhibitors*/chemistry , Cytochrome P-450 CYP3A Inhibitors*/pharmacology , Cytochrome P-450 CYP3A Inhibitors*/metabolism, Humans ; Protein Binding ; Crystallography, X-Ray ; Kinetics ; Catalytic Domain

المؤلفون: Shah MM; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Joyce B; Epic Research, Epic Systems Corporation, Verona, Wisconsin, USA., Plumb ID; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Sahakian S; Epic Research, Epic Systems Corporation, Verona, Wisconsin, USA., Feldstein LR; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Barkley E; Epic Research, Epic Systems Corporation, Verona, Wisconsin, USA., Paccione M; Epic Research, Epic Systems Corporation, Verona, Wisconsin, USA., Deckert J; Epic Research, Epic Systems Corporation, Verona, Wisconsin, USA., Sandmann D; Epic Research, Epic Systems Corporation, Verona, Wisconsin, USA., Hagen MB; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Gerhart JL; Epic Research, Epic Systems Corporation, Verona, Wisconsin, USA.

المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jul 19; Vol. 79 (1), pp. 108-110.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Ritonavir*/therapeutic use , Ritonavir*/administration & dosage , Hospitalization*/statistics & numerical data , COVID-19*/prevention & control , COVID-19*/epidemiology , SARS-CoV-2*/immunology , Antiviral Agents*/therapeutic use , Antiviral Agents*/administration & dosage , COVID-19 Vaccines*/administration & dosage, Humans ; Male ; Middle Aged ; Female ; Adult ; Aged ; Vaccination/statistics & numerical data ; Leucine/analogs & derivatives ; Leucine/therapeutic use ; COVID-19 Drug Treatment ; Lactams ; Nitriles ; Proline